APTIV PLC (APTV) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.61%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.61% | Share-based compensation / revenue. Period ending 2026-06-30. $125.00M ÷ $20.52B × 100 ≈ 0.61% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 20.52B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 125.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.21B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $20.52B | $125.00M | $1.21B | (m) | (m) | 0.61% | (m) | (m) |
| 2026-03-31 | (m) | $20.66B | $131.00M | $1.11B | (m) | (m) | 0.63% | (m) | (m) |
| 2025-12-31 | $1.13B | $20.40B | $139.00M | $1.18B | $361.00M | 5.53% | 0.68% | 3.28× | Reported |
| 2025-09-30 | (m) | $20.15B | $142.00M | $1.24B | (m) | (m) | 0.70% | (m) | (m) |
| 2025-06-30 | (m) | $19.79B | $134.00M | $1.92B | (m) | (m) | 0.68% | (m) | (m) |
| 2025-03-31 | (m) | $19.64B | $125.00M | $1.87B | (m) | (m) | 0.64% | (m) | (m) |
| 2024-12-31 | $1.10B | $19.71B | $120.00M | $1.84B | $337.00M | 5.56% | 0.61% | 5.47× | Reported |
| 2024-09-30 | (m) | $19.73B | $124.00M | $1.72B | (m) | (m) | 0.63% | (m) | (m) |
| 2024-06-30 | (m) | $19.98B | $121.00M | $1.66B | $275.00M | (m) | 0.61% | 6.04× | Reported |
| 2024-03-31 | (m) | $20.13B | $123.00M | $1.63B | $283.00M | (m) | 0.61% | 5.76× | Reported |
| 2023-12-31 | $1.29B | $20.05B | $115.00M | $1.56B | $285.00M | 6.43% | 0.57% | 5.47× | Reported |
| 2023-09-30 | (m) | $19.77B | $103.00M | $1.64B | $276.00M | (m) | 0.52% | 5.96× | Reported |
| 2023-06-30 | (m) | $19.27B | $91.00M | $1.67B | $259.00M | (m) | 0.47% | 6.44× | Reported |
| 2023-03-31 | (m) | $18.13B | $100.00M | $1.35B | $243.00M | (m) | 0.55% | 5.58× | Reported |
| 2022-12-31 | $1.12B | $17.49B | $86.00M | $1.26B | $219.00M | 6.40% | 0.49% | 5.77× | Reported |
| 2022-09-30 | (m) | $16.98B | $76.00M | $1.08B | $193.00M | (m) | 0.45% | 5.61× | Reported |
| 2022-06-30 | (m) | $16.02B | $76.00M | $828.00M | $171.00M | (m) | 0.47% | 4.84× | Reported |
| 2022-03-31 | (m) | $15.77B | $63.00M | $1.02B | $153.00M | (m) | 0.40% | 6.64× | Reported |
| 2021-12-31 | $1.03B | $15.62B | $87.00M | $1.19B | $150.00M | 6.59% | 0.56% | 7.93× | Reported |
| 2021-09-30 | (m) | $15.70B | $112.00M | $1.38B | $153.00M | (m) | 0.71% | 8.99× | Reported |
| 2021-06-30 | (m) | $15.71B | $105.00M | $1.52B | $155.00M | (m) | 0.67% | 9.83× | Reported |
| 2021-03-31 | (m) | $13.86B | $90.00M | $928.00M | $161.00M | (m) | 0.65% | 5.76× | Reported |
| 2020-12-31 | $1.02B | $13.07B | $60.00M | $2.12B | $164.00M | 7.84% | 0.46% | 12.91× | Reported |
| 2020-09-30 | (m) | $12.45B | $47.00M | $2.00B | $166.00M | (m) | 0.38% | 12.02× | Reported |
| 2020-06-30 | (m) | $12.34B | $42.00M | $1.95B | $170.00M | (m) | 0.34% | 11.48× | Reported |
| 2020-03-31 | (m) | $14.01B | $50.00M | $2.60B | $169.00M | (m) | 0.36% | 15.37× | Reported |
| 2019-12-31 | $1.17B | $14.36B | $66.00M | $1.28B | $164.00M | 8.11% | 0.46% | 7.78× | Reported |
| 2019-09-30 | (m) | $14.40B | $68.00M | $1.31B | $160.00M | (m) | 0.47% | 8.17× | Reported |
| 2019-06-30 | (m) | $14.32B | $67.00M | $1.31B | $152.00M | (m) | 0.47% | 8.62× | Reported |
| 2019-03-31 | (m) | $14.38B | $60.00M | $1.40B | $145.00M | (m) | 0.42% | 9.63× | Reported |
| 2018-12-31 | $1.20B | $14.44B | $58.00M | $1.47B | $141.00M | 8.31% | 0.40% | 10.45× | Reported |
| 2018-09-30 | (m) | (m) | $52.00M | $1.50B | $141.00M | (m) | (m) | 10.67× | Reported |
| 2018-06-30 | (m) | (m) | $61.00M | $1.55B | $142.00M | (m) | (m) | 10.94× | Reported |
| 2018-03-31 | (m) | (m) | $62.00M | $1.50B | $141.00M | (m) | (m) | 10.62× | Reported |
| 2017-12-31 | $900.00M | (m) | $62.00M | $1.42B | $140.00M | (m) | (m) | 10.11× | Reported |
| 2017-09-30 | (m) | (m) | $71.00M | $2.09B | $138.00M | (m) | (m) | 15.14× | Reported |
| 2017-06-30 | (m) | (m) | $74.00M | $2.04B | $143.00M | (m) | (m) | 14.27× | Reported |
| 2017-03-31 | (m) | (m) | $68.00M | $1.97B | $149.00M | (m) | (m) | 13.20× | Reported |
| 2016-12-31 | $1.20B | (m) | $68.00M | $1.95B | $156.00M | (m) | (m) | 12.48× | Reported |
| 2016-09-30 | (m) | (m) | $69.00M | $1.63B | $158.00M | (m) | (m) | 10.30× | Reported |
| 2016-06-30 | (m) | (m) | $67.00M | $1.63B | $147.00M | (m) | (m) | 11.07× | Reported |
| 2016-03-31 | (m) | (m) | $78.00M | $1.72B | $136.00M | (m) | (m) | 12.63× | Reported |
| 2015-12-31 | $1.20B | (m) | $74.00M | $1.72B | $127.00M | (m) | (m) | 13.57× | Reported |
| 2015-09-30 | (m) | (m) | $72.00M | $1.85B | $126.00M | (m) | (m) | 14.70× | Reported |
| 2015-06-30 | (m) | (m) | $76.00M | $1.78B | $129.00M | (m) | (m) | 13.82× | Reported |
| 2015-03-31 | (m) | (m) | $76.00M | $1.85B | $132.00M | (m) | (m) | 14.04× | Reported |
| 2014-12-31 | $1.30B | (m) | $76.00M | $1.85B | $135.00M | (m) | (m) | 13.68× | Reported |
| 2014-09-30 | (m) | (m) | $66.00M | $1.78B | $138.00M | (m) | (m) | 12.88× | Reported |
| 2014-06-30 | (m) | (m) | $56.00M | $1.75B | $139.00M | (m) | (m) | 12.60× | Reported |
| 2014-03-31 | (m) | (m) | $51.00M | $1.75B | $142.00M | (m) | (m) | 12.30× | Reported |
| 2013-12-31 | $1.30B | (m) | $47.00M | $1.68B | $143.00M | (m) | (m) | 11.78× | Reported |
| 2013-09-30 | (m) | (m) | $-5.00M | $1.44B | $142.00M | (m) | (m) | 10.17× | Reported |
| 2013-06-30 | (m) | (m) | $-9.00M | $1.42B | $140.00M | (m) | (m) | 10.17× | Reported |
| 2013-03-31 | (m) | (m) | $-15.00M | $1.41B | $137.00M | (m) | (m) | 10.28× | Reported |
| 2012-12-31 | $1.20B | (m) | $-21.00M | $1.48B | $136.00M | (m) | (m) | 10.85× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $1.20B | (m) | $-14.00M | $1.64B | $123.00M | (m) | (m) | 13.37× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $1.00B | (m) | $-5.00M | $940.00M | $30.00M | (m) | (m) | 31.33× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allison Transmission Holdings Inc (ALSN) | United States | $9.313B | 17.68 |
| AUTOLIV INC (ALV) | $8.345B | 13.55 | |
| MODINE MANUFACTURING CO (MOD) | United States | $10.470B | 97.84 |
| BORGWARNER INC (BWA) | United States | $11.911B | 32.82 |
| LEAR CORP (LEA) | United States | $5.831B | 11.79 |
| Garrett Motion Inc. (GTX) | $4.732B | 9.95 | |
| GENTEX CORP (GNTX) | United States | $4.643B | 13.22 |
| Atmus Filtration Technologies Inc. (ATMU) | United States | $3.656B | 19.39 |
| Dorman Products, Inc. (DORM) | United States | $3.641B | 18.26 |
| Versigent PLC (VGNT) | $3.205B |